Cargando…
The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study
INTRODUCTION: Zostavax, a live attenuated vaccine, has been approved in the United States for use in older individuals to reduce the risk and severity of herpes zoster (HZ), also known as shingles. The vaccine is contraindicated in individuals taking anti-tumor necrosis factor alpha (anti-TNF) thera...
Autores principales: | Zhang, Jie, Delzell, Elizabeth, Xie, Fenglong, Baddley, John W, Spettell, Claire, Mcmahan, Raechele M, Fernandes, Joaquim, Chen, Lang, Winthrop, Kevin, Curtis, Jeffrey R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308109/ https://www.ncbi.nlm.nih.gov/pubmed/22024532 http://dx.doi.org/10.1186/ar3497 |
Ejemplares similares
-
Geographic Distribution of Endemic Fungal Infections among Older Persons, United States
por: Baddley, John W., et al.
Publicado: (2011) -
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
por: Marra, Yasmin, et al.
Publicado: (2022) -
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017) -
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
por: Winthrop, Kevin L., et al.
Publicado: (2017) -
Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)